COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,550 Articles (22,881 medRxiv, 8,669 bioRxiv)

Most recent first Previous |  Page 1919: Articles 19181-19190  | Next

A Serology Strategy for Epidemiological Studies Based on the Comparison of the Performance of Seven Different Test Systems - The Representative COVID-19 Cohort Munich
Olbrich, L., Castelletti, N., Schaelte, Y., Gari, M., Puetz, P., Bakuli, A., Pritsch, M., Kroidl, I., Saathoff, E., Guggenbuehl Noller, J. M., Fingerle, V., Le Gleut, R., Gilberg, L., Brand, I., Falk, P., Markgraf, A., Deak, F., Riess, F., Diefenbach, M., Eser, T. M., Weinauer, F., Martin, S., Quenzel, E.-M., Becker, M., Durner, J., Girl, P., Mueller, K., Radon, K., Fuchs, C., Woelfel, R., Hasenauer, J., Hoelscher, M., Wieser, A.
10.1101/2021.01.13.21249735 — Posted: 2021-01-16
Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2
Naushin, S., Sardana, V., Ujjainiya, R., Bhatheja, N., Kutum, R., Bhaskar, A. K., Pradhan, S., Prakash, S., Khan, R., Rawat, B. S., Chandak, G. R., Tallapaka, K. B., Anumalla, M., Lahiri, A., Kar, S., Mulay, S. R., Mugale, M. N., Srivastava, M., Khan, S., Srivastava, A., Tomar, B., Veerapandian, M., Venkatachalam, G., Vijayakumar, S. R., Agarwal, A., Gupta, D., Halami, P. M., Peddha, M. S., M, G., Veeranna, R. P., Pal, A., Agarwal, V. K., Maurya, A. K., Singh, R. K., Raman, A. K., Anandasadagopan, S. K., Karupannan, P., Venkatesan, S., Sardana, H. K., Kothari, A., Jain, R., Thakur, A., Parihar, D. S., Saifi, A., Kaur, J., Kumar, V., Mishra, A., Gogeri, I., Rayasam, G. V., Singh, P., Chakraborty, R., Chaturvedi, G., Karunakar, P., Yadav, R., Singhmar, S., Singh, D., Sarkar, S., Bhattacharya, P., Acharya, S., Singh, V., Verma, S., Soni, D., Seth, S., Fatima, F., Vashisht, S., Thakran, S., Singh, A. P., Sharma, A., Sharma, B., Subramanian, M., Padwad, Y., Hallan, V., Patial, V., Singh, D., Tirpude, N. V., Chakrabarti, P., Maity, S. K., Ganguly, D., Sarkar, J., Ramakrishna, S., Kumar, B. N., Kumar, K. A., Gandhi, S. G., Jamwal, P. S., Chouhan, R., Jamwal, V. L., Kapoor, N., Ghosh, D., Thakkar, G., Subudhi, U., Sen, P., Raychaudhri, S., Tuli, A., Gupta, P., Kumar, R., Sharma, D., Ringe, R. P., D, A., Kulkarni, M., Shanmugam, D., Dharne, M., Dastager, S. G., Joshi, R., Patil, A. P., Mahajan, S. N., Khan, A. J., Wagh, V., Yadav, R., Khilari, A., Bhadange, M., Chaurasiya, A. H., Kulsange, S. E., khairnar, K., Paranjape, S., Kalita, J., Sastry, G. N., Phukan, T., Manna, P., Romi, W., Bharali, P., Ozah, D., Sahu, R. K., Babu, E. V., Sukumaran, R. K., Nair, A. R., Puthiyamadam, A., Valappil, P. K., Velayudhanpillai, A., Chodankar, K., Damare, S., Madhavi, Y., Agrawal, V. V., Dahiya, S., Agrawal, A., Dash, D., Sengupta, S.
10.1101/2021.01.12.21249713 — Posted: 2021-01-16 Discussion: Onsite
Correlation of Computerized Tomography (CT) Severity Score for COVID-19 pneumonia with Clinical Outcomes
Hilal, K., Shahid, J., Aameen, A., Seth Martins, R., Nankani, A., Arshad, A., Tu, H.
10.1101/2021.01.15.426787 — Posted: 2021-01-15
Increased infections, but not viral burden, with a new SARS-CoV-2 variant
Walker, A. S., Vihta, K. D., Gethings, O., Pritchard, E., Jones, J., House, T., Bell, I., Bell, J., Newton, J., Farrar, J., Diamond, I., Studley, R., Rourke, E., Hay, J., Hopkins, S., Crook, D. W., Peto, T., Matthews, P., Eyre, D. W., Stoesser, N. W., Pouwels, K., the COVID-19 Infection Survey team
10.1101/2021.01.13.21249721 — Posted: 2021-01-15 Discussion: Onsite
From SARS and MERS to COVID-19: a review of the quality and responsiveness of clinical management guidelines in outbreak settings
Lipworth, S., Rigby, I., Cheng, V., Bannister, P., Harriss, E., Cook, K., Cai, E., Tattan, M., Epie, T., Manoharan, L., Lambe, K., Michelen, M., Gilibets, A., Dagens, A., Sigfrid, L., Horby, P.
10.1101/2021.01.12.21249654 — Posted: 2021-01-15
SARS-CoV-2 reinfection in a cohort of 43,000 antibody-positive individuals followed for up to 35 weeks
Abu-Raddad, L. J., Chemaitelly, H., Coyle, P., Malek, J. A., Ahmed, A. A., Mohamoud, Y. A., Younuskunju, S., Ayoub, H. H., Al Kanaani, Z., Al Kuwari, E., Butt, A. A., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G. K., Yassine, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Al-Thani, M. H., Al Khal, A., Bertollini, R.
10.1101/2021.01.15.21249731 — Posted: 2021-01-15 Discussion: Onsite
Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments
Cake, C., Ogburn, E., Pinches, H., Coleman, G., Seymour, D., Woodard, F., Manohar, S., Monsur, M., Landray, M., Dalton, G., Morris, A. D., Chinnery, P. F., UK COVID-19 National Core Studies Consortium, , Hobbs, F. D. R., Butler, C.
10.1101/2021.01.15.21249724 — Posted: 2021-01-15
From "don, doff, and discard" to "don, doff, and decontaminate" - determination of filtering facepiece respirator and surgical mask integrity and inactivation of a SARS-CoV-2 surrogate and a small non-enveloped virus following multiple-cycles of vaporised hydrogen peroxide, ultraviolet germicidal irradiation, and dry heat decontamination
Ludwig-Begall, L. F., Wielick, C., Jolois, O., Dams, L., Razafimahefa, R. M., Nauwynck, H., Demeuldre, P.-F., Napp, A., Laperre, J., Farnir, F., Thiry, E., Haubruge, E.
10.1101/2021.01.15.21249866 — Posted: 2021-01-15
CAR-NK Cells Effectively Target the D614 and G614 SARS-CoV-2-infected Cells
Ma, M., Badeti, S., Chen, C.-H., Pinter, A., Jiang, Q., Shi, L., Zhou, R., Xu, H., Li, Q., Gause, W., Liu, D.
10.1101/2021.01.14.426742 — Posted: 2021-01-15
Enhanced Cholesterol-dependent Hemifusion by Internal Fusion Peptide 1 of SARS Coronavirus-2 Compared to its N-terminal Counterpart
Pattnaik, G. P., Bhattacharjya, S., Chakraborty, H.
10.1101/2021.01.14.426613 — Posted: 2021-01-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).